Heck Capital Advisors, LLC Royalty Pharma PLC Transaction History
Heck Capital Advisors, LLC
- $1.47 Trillion
- Q4 2024
A detailed history of Heck Capital Advisors, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Heck Capital Advisors, LLC holds 9 shares of RPRX stock, worth $275. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9Holding current value
$275% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
410Shares Held
284MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.26 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$705 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$494 Million0.35% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$372 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...